2 patients achieved second CR, 1 (No.9) continued to be CR, while the other one (No.19) with ALK-negative ALCL received allogeneic SCT, but died of disease 1 year after bone marrow transplantation. This evidence concerns the gene ALK and anaplastic large cell lymphoma.